We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

68 hedge funds and large institutions have $459M invested in HilleVax in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 9

26% more funds holding

Funds holding: 5468 (+14)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

7.48% more ownership

Funds ownership: 64.81%72.29% (+7.5%)

5% more capital invested

Capital invested by funds: $437M → $459M (+$22.6M)

Holders
68
Holders Change
+14
Holders Change %
+25.93%
% of All Funds
1.08%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
15
Increased
33
Reduced
9
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$132M
DM
2
Deerfield Management
New York
$53.9M +$9.5M +675,000 +20%
DTC
3
Deep Track Capital
Connecticut
$39M +$40.8M +2,900,000 New
VA
4
VR Adviser
New York
$27.4M +$28.7M +2,037,313 New
CG
5
Carlyle Group
District of Columbia
$24.7M
Franklin Resources
6
Franklin Resources
California
$23.9M +$6.89M +489,908 +38%
B
7
Braidwell
Connecticut
$19.5M +$2.81M +200,000 +16%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$19.3M +$99K +7,033 +0.5%
BlackRock
9
BlackRock
New York
$17.3M +$241K +17,110 +1%
Vanguard Group
10
Vanguard Group
Pennsylvania
$15.5M +$3.52M +250,200 +28%
Citadel Advisors
11
Citadel Advisors
Florida
$11.7M +$12.2M +867,213 New
SG
12
StepStone Group
California
$11.1M +$2.11M +149,998 +22%
SB
13
Samsara BioCapital
California
$10.8M +$2.81M +200,000 +33%
Morgan Stanley
14
Morgan Stanley
New York
$8.26M +$309K +21,941 +4%
QUSVM
15
Qiming U.S. Ventures Management
Washington
$7.52M
Geode Capital Management
16
Geode Capital Management
Massachusetts
$5.63M +$858K +60,971 +17%
State Street
17
State Street
Massachusetts
$4.79M +$32.1K +2,282 +0.6%
ACP
18
Acuta Capital Partners
California
$3.64M +$2.92M +207,241 +329%
Adage Capital Partners
19
Adage Capital Partners
Massachusetts
$2.37M +$2.48M +176,512 New
Northern Trust
20
Northern Trust
Illinois
$2.32M +$157K +11,120 +7%
Charles Schwab
21
Charles Schwab
California
$1.96M +$472K +33,508 +30%
6CM
22
683 Capital Management
New York
$1.63M +$1.71M +121,200 New
FAM
23
Fred Alger Management
New York
$1.62M +$473K +33,591 +39%
Ensign Peak Advisors
24
Ensign Peak Advisors
Utah
$1.58M
UOC
25
UBS O'Connor
Illinois
$1.54M +$479K +34,000 +42%

HLVX Hedge Fund Activity: Q3 2023 in Review

68 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q3 2023, worth a combined $459M — up 5.2% from $437M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new HLVX positions and 0 closed out — a net gain of 15 holders — while 33 added to existing stakes and 9 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $40.8M. The largest seller was Deutsche Bank, cutting an estimated $1.39M.

  • 68 institutional investors held HilleVax (HLVX) as of Q3 2023, up from 54 in Q2 2023.
  • Funds reported $459M of HilleVax stock for Q3 2023, up 5.2% quarter-over-quarter.
  • 15 funds opened new HilleVax positions in Q3 2023 and 0 closed out, a net change of +15 holders.
  • The largest HilleVax buyer in Q3 2023 was Deep Track Capital, an estimated $40.8M added.
  • The largest HilleVax seller in Q3 2023 was Deutsche Bank, an estimated $1.39M sold.

Based on aggregated 13F filings for Q3 2023.